Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FHTX Foghorn Therapeutics Inc.

已收盘 04-08 16:00:00 EDT

4.89

-0.08

-1.61%

盘后4.89

+0.000.00%

17:57 EDT

最高5.20	最低4.82	成交量15.25万
今开5.18	昨收4.97	日振幅7.65%
总市值2.86亿	流通市值1.41亿	总股本5,858万
成交额75.07万	换手率0.53%	流通股本2,887万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FHTX","market":"US","secType":"STK","nameCN":"Foghorn Therapeutics Inc.","latestPrice":4.89,"timestamp":1775678400000,"preClose":4.97,"halted":0,"volume":152481,"hourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.89,"latestTime":"17:57 EDT","volume":8753,"amount":42802.69,"timestamp":1775685457829,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.016096579476861182,"floatShares":28868800,"shares":58581600,"eps":-1.18,"marketStatus":"已收盘","change":-0.08,"latestTime":"04-08 16:00:00 EDT","open":5.18,"high":5.2,"low":4.82,"amount":750718.356425,"amplitude":0.076459,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.18,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1775721600000},"marketStatusCode":5,"adr":0,"listingDate":1603425600000,"exchange":"NASDAQ","adjPreClose":4.97,"preHourTrading":{"tag":"盘前","latestPrice":5.2,"preClose":4.97,"latestTime":"08:35 EDT","volume":4,"amount":20.8,"timestamp":1775651728908,"change":0.23,"changeRate":0.046278,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.89,"preClose":4.89,"latestTime":"17:57 EDT","volume":8753,"amount":42802.69,"timestamp":1775685457829,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.455822,"impliedVol":1.0863,"impliedVolPercentile":0.328},"requestUrl":"/m/hq/s/FHTX","defaultTab":"news","newsList":[{"id":"1154855991","title":"Foghorn Therapeutics任命Ryan Maynard为首席财务官，强化财务领导团队","url":"https://stock-news.laohu8.com/highlight/detail?id=1154855991","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154855991?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:02","pubTimestamp":1771848135,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc. (FHTX) 宣布任命Ryan Maynard为公司新任首席财务官，此举旨在加强其财务管理团队的实力。Maynard将负责领导公司的财务战略规划、资本管理及投资者关系等核心事务，为公司的长期发展提供坚实的财务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605284724","title":"Foghorn Therapeutics Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605284724?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:00","pubTimestamp":1769198414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日04时00分，Foghorn Therapeutics Inc.股票出现异动，股价急速跳水5.16%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Coherus Oncology, Inc.、Collplant Biotechnologies Ltd.、Scinai Immunotherapeutics Ltd涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1447.84%、165.05%、50.83%，振幅较大的相关个股有Revelation Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为99.49%、60.41%、58.89%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4007","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167611957","title":"Foghorn Therapeutics完成5000万美元注册直接融资，发行价溢价30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167611957","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167611957?lang=zh_cn&edition=full","pubTime":"2026-01-14 05:06","pubTimestamp":1768338403,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Foghorn Therapeutics Inc.今日宣布，已完成一笔5000万美元的注册直接融资，发行价较市场价溢价30%。此次发行以每股6.71美元的价格售出2,030,314股普通股。所有股份均由Foghorn出售，融资总收益约为5000万美元。Foghorn Therapeutics致力于发现和开发一类新型药物，靶向染色质调控系统中由基因决定的依赖性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","FHTX","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146675657","title":"Foghorn Therapeutics 第三季度每股收益为 -0.25 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146675657","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146675657?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:42","pubTimestamp":1763570551,"startTime":"0","endTime":"0","summary":"11月5日 - Foghorn Therapeutics 第三季度的合作收入为 815.3 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583631770","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583631770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583631770?lang=zh_cn&edition=full","pubTime":"2025-11-15 00:39","pubTimestamp":1763138374,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日00时39分，Foghorn Therapeutics Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报4.58美元/股，成交量2.9684万股，换手率0.05%，振幅7.57%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115003935a4a20ce6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115003935a4a20ce6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","FHTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105278157","title":"Foghorn Therapeutics Inc. - Kristian Humer于10月31日辞去CFO职务，生效日期为2025年11月14日 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1105278157","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105278157?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:11","pubTimestamp":1762344684,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc. - Kristian Humer于10月31日辞去CFO职务，生效日期为2025年11月14日 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122526870","title":"Foghorn Therapeutics公布选择性Arid1b、选择性Cbp和选择性Ep300降解剂项目的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1122526870","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122526870?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:31","pubTimestamp":1761823877,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics公布选择性Arid1b、选择性Cbp和选择性Ep300降解剂项目的最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578506487","title":"Foghorn Therapeutics Inc.盘中异动 下午盘大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578506487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578506487?lang=zh_cn&edition=full","pubTime":"2025-10-25 02:58","pubTimestamp":1761332298,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日02时58分，Foghorn Therapeutics Inc.股票出现异动，股价大幅上涨5.13%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Inhibrx Biosciences, Inc.、Genenta Science Spa、Theriva Biologics, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Theriva Biologics, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为3431.16%、2773.06%、2471.01%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025025819a6cc873c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025025819a6cc873c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","FHTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116612316","title":"Foghorn Therapeutics在第八届TPD及诱导接近峰会上宣布选择性Arid1b降解剂的重要进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1116612316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116612316?lang=zh_cn&edition=full","pubTime":"2025-10-16 19:01","pubTimestamp":1760612477,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics在第八届TPD及诱导接近峰会上宣布选择性Arid1b降解剂的重要进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573967648","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大涨6.84%报4.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573967648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573967648?lang=zh_cn&edition=full","pubTime":"2025-10-07 21:45","pubTimestamp":1759844712,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日21时45分，Foghorn Therapeutics Inc.股票出现波动，股价急速拉升6.84%。截至发稿，该股报4.84美元/股，成交量3875股，换手率0.01%，振幅2.43%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510072145129722a5b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510072145129722a5b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","BK4007","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518126227","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518126227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518126227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Foghorn Therapeutics Inc.股票出现波动，股价大幅下挫6.63%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为447.98%、67.42%、50.45%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517147501","title":"Foghorn Therapeutics(FHTX.US)：2024年Q4财报实现营收285.6万美元，前值为576.9万美元，预期值为814万美元；每股收益为-0.23美元，前值为-0.57美元，预期值为-0.27美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147501","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147501?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:03","pubTimestamp":1741302184,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics(FHTX.US)：2024年Q4财报实现营收285.6万美元，前值为576.9万美元，预期值为814万美元；每股收益为-0.23美元，前值为-0.57美元，预期值为-0.27美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070348578858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161545004","title":"Foghorn Therapeutics 2024财年GAAP每股收益$(1.58)优于$(1.61)预期，销售额$2260.2万低于$3071.3万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1161545004","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161545004?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:18","pubTimestamp":1741295920,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics 报告季度每股亏损$，优于分析师预期的$，超出1.86%。公司报告季度销售额为$2260.2万，低于分析师预期的$3071.3万，低于预期26.41%。相比去年同期的$3415.5万，减少了33.83%。以上内容来自Benzinga Earnings专栏，原文如下：Foghorn $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 1.86 percent. This is a 32.48 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $22.602 million which missed the analyst consensus estimate of $30.713 million by 26.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517592359","title":"Foghorn Therapeutics Inc.盘中异动 急速上涨6.29%报4.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517592359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517592359?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:59","pubTimestamp":1741201172,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时59分，Foghorn Therapeutics Inc.股票出现波动，股价快速上涨6.29%。截至发稿，该股报4.67美元/股，成交量2.7506万股，换手率0.05%，振幅6.43%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.70%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634467","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速下挫6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634467?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分，Foghorn Therapeutics Inc.股票出现波动，股价急速下挫6.19%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.51%、32.99%、31.59%，振幅较大的相关个股有Entero Therapeutics Inc.、Pliant Therapeutics, Inc.、Spruce Biosciences, Inc.，振幅分别为21.22%、19.85%、19.25%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FHTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516372537","title":"Foghorn Therapeutics Inc.盘中异动 急速拉升5.18%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372537?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:09","pubTimestamp":1740762550,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时09分，Foghorn Therapeutics Inc.股票出现波动，股价急速拉升5.18%。截至发稿，该股报4.87美元/股，成交量2.5705万股，换手率0.05%，振幅5.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514380125","title":"Foghorn Therapeutics Inc.盘中异动 快速下挫5.19%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380125?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:53","pubTimestamp":1740675183,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时53分，Foghorn Therapeutics Inc.股票出现异动，股价快速下跌5.19%。截至发稿，该股报4.75美元/股，成交量4.439万股，换手率0.08%，振幅7.58%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513291109","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513291109?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:09","pubTimestamp":1740150579,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时09分，Foghorn Therapeutics Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报5.11美元/股，成交量4.9109万股，换手率0.09%，振幅7.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169426","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169426?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889118,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Foghorn Therapeutics Inc.股票出现波动，股价快速拉升5.87%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.68%、90.87%、59.60%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、6.84%、6.13%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511821576","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨5.50%报5.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511821576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511821576?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:26","pubTimestamp":1739471165,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时26分，Foghorn Therapeutics Inc.股票出现波动，股价急速上涨5.50%。截至发稿，该股报5.82美元/股，成交量6.0915万股，换手率0.11%，振幅6.27%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140226059621e9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140226059621e9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FHTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://foghorntx.com","stockEarnings":[{"period":"1week","weight":0.0397},{"period":"1month","weight":-0.1401},{"period":"3month","weight":-0.0551},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.3505},{"period":"ytd","weight":-0.0796}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":-0.0196},{"period":"3month","weight":-0.044},{"period":"6month","weight":-0.0178},{"period":"1year","weight":0.307},{"period":"ytd","weight":-0.0333}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Foghorn Therapeutics Inc.于2015年10月作为特拉华州公司成立。该公司是一家临床阶段的精准治疗生物技术公司，率先开发一类靶向染色质调控系统以纠正异常基因表达的新型药物。其专有的Gene Traffic Control平台能够对该系统进行整合研究和靶向，其研发管线专注于肿瘤学，并有可能应用于其他疾病领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.121231},{"month":2,"riseRate":0.333333,"avgChangeRate":0.145296},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.011711},{"month":4,"riseRate":0.5,"avgChangeRate":-0.058361},{"month":5,"riseRate":0.4,"avgChangeRate":0.013007},{"month":6,"riseRate":0.8,"avgChangeRate":0.067343},{"month":7,"riseRate":0.8,"avgChangeRate":0.112962},{"month":8,"riseRate":0.4,"avgChangeRate":0.016047},{"month":9,"riseRate":0.4,"avgChangeRate":-0.062466},{"month":10,"riseRate":0.2,"avgChangeRate":-0.136011},{"month":11,"riseRate":0.666667,"avgChangeRate":0.057074},{"month":12,"riseRate":0.666667,"avgChangeRate":0.19509}],"exchange":"NASDAQ","name":"Foghorn Therapeutics Inc.","nameEN":"Foghorn Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Foghorn Therapeutics Inc.,FHTX,Foghorn Therapeutics Inc.股票,Foghorn Therapeutics Inc.股票老虎,Foghorn Therapeutics Inc.股票老虎国际,Foghorn Therapeutics Inc.行情,Foghorn Therapeutics Inc.股票行情,Foghorn Therapeutics Inc.股价,Foghorn Therapeutics Inc.股市,Foghorn Therapeutics Inc.股票价格,Foghorn Therapeutics Inc.股票交易,Foghorn Therapeutics Inc.股票购买,Foghorn Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}